Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Chen Chang, Ya-Ping Chen, L. Jeffrey Medeiros, Tsai-Yun Chen & Kung-Chao Chang. (2021) Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 62:1, pages 76-85.
Read now
Read now
Monika Anna Grygorowicz, Marzena Biernacka, Mateusz Bujko, Eliza Nowak, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Ilona Sara Borycka, Zbigniew Bystydzienski, Jan Walewski & Sergiusz Markowicz. (2016) Human regulatory T cells suppress proliferation of B lymphoma cells. Leukemia & Lymphoma 57:8, pages 1903-1920.
Read now
Read now
Morihiro Higashi, Michihide Tokuhira, Satoshi Fujino, Takahisa Yamashita, Keiko Abe, Eiichi Arai, Masahiro Kizaki & Jun-ichi Tamaru. (2016) Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:1, pages 161-166.
Read now
Read now
Claire Germain, Thierry Guillaudeux, Elisabeth D Galsgaard, Catherine Hervouet, Nedra Tekaya, Anne-Sophie Gallouet, Julien Fassy, Franck Bihl, Gwenola Poupon, Anne Lazzari, Pieter Spee, Fabienne Anjuère, Céline Pangault, Karin Tarte, Patrick Tas, Luc Xerri & Veronique M Braud. (2015) Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions. OncoImmunology 4:8.
Read now
Read now
Soo Jeong Nam, Heounjeong Go, Jin Ho Paik, Tae Min Kim, Dae Seog Heo, Chul Woo Kim & Yoon Kyung Jeon. (2014) An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leukemia & Lymphoma 55:11, pages 2466-2476.
Read now
Read now
Xiao-Qian Liu, Kang Lu, Li-Li Feng, Mei Ding, Jun-Ming Gao, Xue-Ling Ge & Xin Wang. (2014) Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration. Leukemia & Lymphoma 55:2, pages 405-414.
Read now
Read now
Rita Coutinho & John Gribben. (2013) Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis. Current Biomarker Findings 3, pages 17-34.
Read now
Read now
Anthony Mato, Tatyana Feldman, Tania Zielonka, Arun Singavi, Gabriella Gadaletta, Kathryn Waksmundzki, Pritish Bhattacharyya, Kar Fai Chow, Xiao Yang, David Panush, Harry Agress, Maria Rosario, Christina Howlett, Andrew Pecora & Andre Goy. (2013) Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma. Leukemia & Lymphoma 54:12, pages 2606-2612.
Read now
Read now
Alakananda Dasgupta, Manoranjan Mahapatra & Renu Saxena. (2013) Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3. Leukemia & Lymphoma 54:4, pages 778-789.
Read now
Read now
Blanca Xicoy, Josep-Maria Ribera, José-luís Mate, Gustavo Tapia, Mireia Morgades, José-Tomás Navarro, Carolina Sanz, Aurelio Ariza & Evarist Feliu. (2010) Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection. Leukemia & Lymphoma 51:11, pages 2063-2069.
Read now
Read now
Ana I. Sáez, Mónica García-Cosío, Antonio J. Sáez, Jesús M. Hernández, Lidia Sánchez-Verde, David Álvarez, Paloma de la Cueva, Reyes Arranz, Eulogio Conde, Carlos Grande, José Rodríguez, Dolores Caballero & Miguel Á. Piris. (2009) Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 50:4, pages 571-581.
Read now
Read now
Paola A Bignone & Alison H Banham. (2008) FOXP3+ regulatory T cells as biomarkers in human malignancies. Expert Opinion on Biological Therapy 8:12, pages 1897-1920.
Read now
Read now
Lisa Rimsza. (2008) Regulating the suppressors: Helpful or harmful?. Leukemia & Lymphoma 49:2, pages 179-180.
Read now
Read now
Articles from other publishers (66)
Kristin Stirm, Peter Leary, Daria Wüst, Dominique Stark, Nicole Joller, Ufuk Karakus, Onur Boyman, Alexandar Tzankov & Anne Müller. (2023) Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. Journal for ImmunoTherapy of Cancer 11:2, pages e006263.
Crossref
Crossref
Wern Lynn Ng, Stephen M. Ansell & Patrizia Mondello. (2022) Insights into the tumor microenvironment of B cell lymphoma. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Yuping Bai, Tingting He, Liyan Zhang, Qianqian Liu, Jing Yang, Ziru Zhao, Kehu Yang & Min Zhang. (2022)
Prognostic value of FOXP3
+
regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
. BMJ Open 12:9, pages e060659.
Crossref
Crossref
Anthony R. Colombo, Monirath Hav, Mohan Singh, Alexander Xu, Alicia Gamboa, Tucker Lemos, Erik Gerdtsson, Denaly Chen, Jane Houldsworth, Rita Shaknovich, Tomohiro Aoki, Lauren Chong, Katsuyoshi Takata, Elizabeth A. Chavez, Christian Steidl, James Hicks, Peter Kuhn, Imran Siddiqi & Akil Merchant. (2022) Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma. Blood Advances 6:16, pages 4675-4690.
Crossref
Crossref
Kamira Maharaj, Angimar Uriepero, Eva Sahakian & Javier Pinilla-Ibarz. (2022) Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. Frontiers in Immunology 13.
Crossref
Crossref
Yang Zhao, Hui Xu, Mingzhi Zhang & Ling Li. (2022) Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma. Frontiers in Genetics 13.
Crossref
Crossref
Carlos Cuesta-Mateos, Fernando Terrón & Marco Herling. (2021) CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target. Frontiers in Oncology 11.
Crossref
Crossref
Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Adrián Arnaiz-Leché & Sergio Roa. (2021) The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. Cancers 13:18, pages 4683.
Crossref
Crossref
Tianqi Xu, Jia Chai, Kaijing Wang, Qingge Jia, Yixiong Liu, Yingmei Wang, Junpeng Xu, Kangjie Yu, Danhui Zhao, Jing Ma, Linni Fan, Qingguo Yan, Shuangping Guo, Gang Chen, Qiongrong Chen, Hualiang Xiao, Fang Liu, Chubo Qi, Rong Liang, Mingyang Li & Zhe Wang. (2021) Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Crossref
Xiyan Tan, Fuyang Cao, Feiyu Tang, Can Lu, Qiaoyan Yu, Songshan Feng, Zhanghuan Yang, Songming Chen, Xiang He, Jiang He, Liang Weng & Lunquan Sun. (2021) Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration. Journal of Immunology Research 2021, pages 1-13.
Crossref
Crossref
Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla & Vassiliki Pappa. (2021) Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. Therapeutic Advances in Hematology 12, pages 204062072110139.
Crossref
Crossref
Gaurav K. Gupta, Tanupriya Agrawal & Monika Pilichowska. (2020) Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings. BMC Cancer 20:1.
Crossref
Crossref
Fei Peng, You Qin, Shidai Mu, Jingwen Li, Lisha Ai & Yu Hu. (2020) Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 146:12, pages 3123-3135.
Crossref
Crossref
Lei Jiang & Nailin Li. (2020) B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy. Angiogenesis 23:4, pages 515-529.
Crossref
Crossref
James W. Vaughan, Min Shi, Pedro Horna & Horatiu Olteanu. (2020) Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells. Annals of Diagnostic Pathology 48, pages 151585.
Crossref
Crossref
Mehdi Dehghani, Mehdi Kalani, Hossein Golmoghaddam, Mani Ramzi & Nargess Arandi. (2020) Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma. Cancer Immunology, Immunotherapy 69:9, pages 1917-1928.
Crossref
Crossref
Alexandra Ioana Cioroianu, Patricia Irina Stinga, Liana Sticlaru, Mirela Daniela Cioplea, Luciana Nichita, Cristiana Popp & Florica Staniceanu. (2019) Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis. Analytical Cellular Pathology 2019, pages 1-9.
Crossref
Crossref
Rui Chen, Yi Gong, Dongling Zou, Lifeng Wang, Li Yuan & Qi Zhou. (2019) Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer. PeerJ 7, pages e7804.
Crossref
Crossref
İrfan Kara, Sedat Çağlı, Alperen Vural, İmdat Yüce, Mete Gündoğ, Kemal Deniz & Kerem Kökoğlu. (2019) The effect of FoxP3 on tumour stage, treatment response, recurrence and survivalability in nasopharynx cancer patients. Clinical Otolaryngology 44:3, pages 349-355.
Crossref
Crossref
Zhanshan Cha, Haihui Gu, Yan Zang, Zi Wang, Jinqi Li, Weihua Huang, Aihua Qin, Lishuang Zhu, Xiaohua Tu, Ning Cheng, Haihan Song & Baohua Qian. (2018) The prevalence and function of CD4 + CXCR5 + Foxp3 + follicular regulatory T cells in diffuse large B cell lymphoma. International Immunopharmacology 61, pages 132-139.
Crossref
Crossref
Christopher Hartley, James W Vaughan, Jason Jarzembowski, Steven H Kroft, Paul Hosking, Alexandra M Harrington & Horatiu Olteanu. (2017) CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration. American Journal of Clinical Pathology 148:6, pages 485-493.
Crossref
Crossref
Michael J. Flynn & John A. Hartley. (2017) The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer. British Journal of Haematology 179:1, pages 20-35.
Crossref
Crossref
Marwa M. Serag El-Dien, Asmaa G. Abdou, Nancy Y. Asaad, Moshira M. Abd El-Wahed & Mona Abd El-Hamid M. Kora. (2017) Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma. Applied Immunohistochemistry & Molecular Morphology 25:8, pages 534-542.
Crossref
Crossref
Ghada Mohamed, Iman L. Abulkheir & Magda Mourad. (2017) FOXP3-positive regulatory T cells are correlated with improved survival in diffuse large B-cell non-Hodgkin lymphoma. Egyptian Journal of Pathology 37:1, pages 104-111.
Crossref
Crossref
C.F. Muir, S.L. Priestnall, A. Hibbert, C. Brown, O.A. Garden & T. Scase. (2017) Prevalence of FoxP3+ Cells Does Not Correlate With Ki67 Expression in Canine Diffuse Large B-cell Lymphoma. Journal of Comparative Pathology 157:1, pages 15-22.
Crossref
Crossref
Monika Anna Grygorowicz, Ilona Sara Borycka, Eliza Nowak, Ewa Paszkiewicz-Kozik, Grzegorz Rymkiewicz, Katarzyna Błachnio, Marzena Biernacka, Mateusz Bujko, Jan Walewski & Sergiusz Markowicz. (2016) Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation. Clinical and Experimental Medicine 17:2, pages 193-207.
Crossref
Crossref
Daniel Bethmann, Zipei Feng & Bernard A Fox. (2017) Immunoprofiling as a predictor of patient’s response to cancer therapy—promises and challenges. Current Opinion in Immunology 45, pages 60-72.
Crossref
Crossref
Shoko NakayamaTaiji YokoteToshikazu AkiokaNobuya HiraokaUta NishiwakiTakuji MiyoshiKazuki IwakiAyami TakayamaYuki MasudaJun HatookaMayumi FujimotoYasuichiro Nishimura & Motomu Tsuji. (2017) Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified. Blood Advances 1:8, pages 486-493.
Crossref
Crossref
Seul Lee, Dong Hyun Kim, Sung Yong Oh, So Yeon Kim, Myeong Seok Koh, Ji Hyun Lee, Suee Lee, Sung-Hyun Kim, Jong-Young Kwak, Min Gyoung Pak, Mi Ha Ju, Hyo-Jin Kim & Jin Sook Jeong. (2017) Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy. The Korean Journal of Internal Medicine 32:2, pages 335-344.
Crossref
Crossref
Guozhen LiuJing LuanQiang Li. (2016)
CD4
+
Foxp3
−
IL-10
+
Tr1 Cells Promote Relapse of Diffuse Large B Cell Lymphoma by Enhancing the Survival of Malignant B Cells and Suppressing Antitumor T Cell Immunity
. DNA and Cell Biology 35:12, pages 845-852.
Crossref
Crossref
Ruifang Sun, L Jeffrey Medeiros & Ken H Young. (2016) Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine. Modern Pathology 29:10, pages 1118-1142.
Crossref
Crossref
Eren Gunduz, Serap Sermet & Ahmet Musmul. (2016) Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients. Cytometry Part B: Clinical Cytometry 90:5, pages 449-454.
Crossref
Crossref
Małgorzata Rusak, Łukasz Bołkun, Joanna Chociej-Stypułkowska, Joanna Pawlus, Janusz Kłoczko & Milena Dąbrowska. (2016) Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients. Blood Cells, Molecules, and Diseases 59, pages 92-96.
Crossref
Crossref
Juan C. Gomez-Gelvez, Mohamed E. Salama, Sherrie L. Perkins, Matthew Leavitt & Kedar V. Inamdar. (2016) Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy. American Journal of Clinical Pathology 145:4, pages 514-523.
Crossref
Crossref
Chen Chang, Shang-Yin Wu, Yu-Wei Kang, Kun-Piao Lin, Tsai-Yun Chen, L. Jeffrey Medeiros & Kung-Chao Chang. (2015) High Levels of Regulatory T Cells in Blood Are a Poor Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma. American Journal of Clinical Pathology 144:6, pages 935-944.
Crossref
Crossref
Daan DierickxThomas Tousseyn & Olivier Gheysens. (2015) How I treat posttransplant lymphoproliferative disorders. Blood 126:20, pages 2274-2283.
Crossref
Crossref
Antonino Carbone & Anas YounesGabriela Gualco & Carlos E Bacchi. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2)
98
111
.
David Berglund, Amelie Kinch, Elin Edman, Carin Backlin, Gunilla Enblad, Erik Larsson, Daniel Molin, Karlis Pauksens, Christer Sundström & Eva Baecklund. (2015) Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders. Transplantation 99:5, pages 1036-1042.
Crossref
Crossref
Matthew J. Ahearne, Kaljit Bhuller, Roger Hew, Hazem Ibrahim, Kikkeri Naresh & Simon D. Wagner. (2014) Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma. Virchows Archiv 465:3, pages 351-358.
Crossref
Crossref
Dammy Pinheiro, Yu-Mei Chang, Hannah Bryant, Balazs Szladovits, Tim Dalessandri, Lucy J. Davison, Elizabeth Yallop, Emily Mills, Chiara Leo, Ana Lara, Anneliese Stell, Gerry Polton & Oliver A. Garden. (2014) Dissecting the Regulatory Microenvironment of a Large Animal Model of Non-Hodgkin Lymphoma: Evidence of a Negative Prognostic Impact of FOXP3+ T Cells in Canine B Cell Lymphoma. PLoS ONE 9:8, pages e105027.
Crossref
Crossref
Magdalena Głowala-Kosińska, Agata Chwieduk, Jarosław Nieckula, Maria Saduś-Wojciechowska, Sebastian Grosicki, Aleksandra Rusin, Elżbieta Nowara & Sebastian Giebel. (2013) Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma. European Journal of Haematology 91:2, pages 122-128.
Crossref
Crossref
Myoung Jae Kang, Kyoung Min Kim, Jun Sang Bae, Ho Sung Park, Ho Lee, Myoung Ja Chung, Woo Sung Moon, Dong Geun Lee & Kyu Yun Jang. (2013) Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma. Translational Oncology 6:3, pages 282-289.
Crossref
Crossref
Sylvia Feyler, Peter J. Selby & Gordon Cook. (2013) Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM). Blood Reviews 27:3, pages 155-164.
Crossref
Crossref
Camilla A. Lindqvist & Angelica S. I. Loskog. (2012) T regulatory cells in B‐cell malignancy – tumour support or kiss of death?. Immunology 135:4, pages 255-260.
Crossref
Crossref
V. Procházka, M. Jarošová, Z. Prouzová, R. Nedomová, T. Papajík & K. Indrák. (2012) Immune Escape Mechanisms in Diffuse Large B-Cell Lymphoma. ISRN Immunology 2012, pages 1-6.
Crossref
Crossref
Jae-Yong Kwak. (2012) Treatment of Diffuse Large B Cell Lymphoma. The Korean Journal of Internal Medicine 27:4, pages 369.
Crossref
Crossref
Matilde Cacciatore, Carla Guarnotta, Marco Calvaruso, Sabina Sangaletti, Ada Maria Florena, Vito Franco, Mario Paolo Colombo & Claudio Tripodo. (2012) Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas. Advances in Hematology 2012, pages 1-12.
Crossref
Crossref
D G Stover, V K Reddy, Y Shyr, B N Savani & N Reddy. (2011) Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma. Bone Marrow Transplantation 47:1, pages 82-87.
Crossref
Crossref
Jing Wang & Xiao-Yan Ke. (2011) The Four types of Tregs in malignant lymphomas. Journal of Hematology & Oncology 4:1.
Crossref
Crossref
Ki Hwan Kim, Tae Min Kim, Heounjeong Go, Wook Youn Kim, Yoon Kyung Jeon, Se‐Hoon Lee, Dong‐Wan Kim, Sang In Khwarg, Chul‐Woo Kim & Dae Seog Heo. (2011) Clinical significance of tumor‐infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa‐associated lymphoid tissue lymphoma. Cancer Science 102:11, pages 1972-1976.
Crossref
Crossref
Reginald M. Gorczynski, David A. Clark, Nuray Erin & Ismat Khatri. (2010) Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice. Breast Cancer Research and Treatment 130:1, pages 49-60.
Crossref
Crossref
Makoto Miyara, Guy Gorochov, Michael Ehrenstein, Lucile Musset, Shimon Sakaguchi & Zahir Amoura. (2011) Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmunity Reviews 10:12, pages 744-755.
Crossref
Crossref
R A Wilcox, K Ristow, T M Habermann, D J Inwards, I N M Micallef, P B Johnston, J P Colgan, G S Nowakowski, S M Ansell, T E Witzig, S N Markovic & L Porrata. (2011) The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 25:9, pages 1502-1509.
Crossref
Crossref
Camilla A. Lindqvist, Lisa H. Christiansson, Ingrid Thörn, Sara Mangsbo, Gabriella Paul-Wetterberg, Christer Sundström, Thomas H. Tötterman, Bengt Simonsson, Gunilla Enblad, Per Frisk, Ulla Olsson-Strömberg & Angelica S.I. Loskog. (2011) Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro. Immunology 133:3, pages 296-306.
Crossref
Crossref
Mary L. Disis. (2011) Immunologic biomarkers as correlates of clinical response to cancer immunotherapy. Cancer Immunology, Immunotherapy 60:3, pages 433-442.
Crossref
Crossref
Walayat Shah, Xiaofei Yan, Li Jing, Yi Zhou, Hongwei Chen & Yili Wang. (2010) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cellular & Molecular Immunology 8:1, pages 59-66.
Crossref
Crossref
Yi-Lan Zhang, Jiang Li, Hao-Yuan Mo, Fang Qiu, Li-Min Zheng, Chao-Nan Qian & Yi-Xin Zeng. (2010) Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Molecular Cancer 9:1.
Crossref
Crossref
Daisuke Ito, Timothy D. O'Brien & Jaime F. Modiano. (2010) Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet). Veterinary Clinical Pathology 39:4, pages 494-498.
Crossref
Crossref
Andrea Ladányi, Anita Mohos, Beáta Somlai, Gabriella Liszkay, Katalin Gilde, Zsuzsanna Fejős, István Gaudi & József Tímár. (2010) FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma. Pathology & Oncology Research 16:3, pages 303-309.
Crossref
Crossref
Ji‐Youn Sung, Sung‐Jig Lim, Youn Wha Kim & Juhie Lee. (2010) Prognostic significance of pSTAT3 and Survivin expression in diffuse large B‐cell lymphoma. Basic and Applied Pathology 3:1, pages 7-13.
Crossref
Crossref
Dimitrios Mougiakakos, Aniruddha Choudhury, Alvaro Lladser, Rolf Kiessling & C. Christian Johansson. 2010.
57
117
.
Roch Houot, Matthew J. Goldstein, Holbrook E. Kohrt, June H. Myklebust, Ash A. Alizadeh, Jack T. LinJonathan M. Irish, James A. Torchia, Arne Kolstad, Lieping Chen & Ronald Levy. (2009) Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood 114:16, pages 3431-3438.
Crossref
Crossref
W.Y. Kim, Y.K. Jeon, T.M. Kim, J.E. Kim, Y.A. Kim, S.-H. Lee, D.-W. Kim, D.S. Heo & C.-W. Kim. (2009) Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Annals of Oncology 20:10, pages 1688-1696.
Crossref
Crossref
Joel M. Baumgartner & Martin D. McCarter. (2009) Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. Surgery 145:4, pages 345-350.
Crossref
Crossref
D. de Jong & G. Enblad. (2008) Inflammatory cells and immune microenvironment in malignant lymphoma. Journal of Internal Medicine 264:6, pages 528-536.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:3, pages 184-191.
Crossref
Crossref